Viral Macrodomains: Unique Mediators of Viral Replication and Pathogenesis
- PMID: 29268982
- PMCID: PMC6003825
- DOI: 10.1016/j.tim.2017.11.011
Viral Macrodomains: Unique Mediators of Viral Replication and Pathogenesis
Abstract
Viruses from the Coronaviridae, Togaviridae, and Hepeviridae families all contain genes that encode a conserved protein domain, called a macrodomain; however, the role of this domain during infection has remained enigmatic. The recent discovery that mammalian macrodomain proteins enzymatically remove ADP-ribose, a common post-translation modification, from proteins has led to an outburst of studies describing both the enzymatic activity and function of viral macrodomains. These new studies have defined these domains as de-ADP-ribosylating enzymes, which indicates that these viruses have evolved to counteract antiviral ADP-ribosylation, likely mediated by poly-ADP-ribose polymerases (PARPs). Here, we comprehensively review this rapidly expanding field, describing the structures and enzymatic activities of viral macrodomains, and discussing their roles in viral replication and pathogenesis.
Keywords: ADP-ribosylation; Coronaviridae; Hepeviridae; Togaviridae; interferon (IFN); macrodomain; pathogenesis; poly-ADP-ribose polymerase (PARP); replication.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Figures



Similar articles
-
The Viral Macrodomain Counters Host Antiviral ADP-Ribosylation.Viruses. 2020 Mar 31;12(4):384. doi: 10.3390/v12040384. Viruses. 2020. PMID: 32244383 Free PMC article. Review.
-
The coronavirus macrodomain is required to prevent PARP-mediated inhibition of virus replication and enhancement of IFN expression.PLoS Pathog. 2019 May 16;15(5):e1007756. doi: 10.1371/journal.ppat.1007756. eCollection 2019 May. PLoS Pathog. 2019. PMID: 31095648 Free PMC article.
-
Viral macrodomains: a structural and evolutionary assessment of the pharmacological potential.Open Biol. 2020 Nov;10(11):200237. doi: 10.1098/rsob.200237. Epub 2020 Nov 18. Open Biol. 2020. PMID: 33202171 Free PMC article.
-
The search for inhibitors of macrodomains for targeting the readers and erasers of mono-ADP-ribosylation.Drug Discov Today. 2021 Nov;26(11):2547-2558. doi: 10.1016/j.drudis.2021.05.007. Epub 2021 May 21. Drug Discov Today. 2021. PMID: 34023495 Review.
-
Mutation of a highly conserved isoleucine residue in loop 2 of several β-coronavirus macrodomains indicates that enhanced ADP-ribose binding is detrimental for replication.J Virol. 2024 Nov 19;98(11):e0131324. doi: 10.1128/jvi.01313-24. Epub 2024 Oct 10. J Virol. 2024. PMID: 39387584 Free PMC article.
Cited by
-
Structural Insights into Plasticity and Discovery of Remdesivir Metabolite GS-441524 Binding in SARS-CoV-2 Macrodomain.ACS Med Chem Lett. 2021 Mar 16;12(4):603-609. doi: 10.1021/acsmedchemlett.0c00684. eCollection 2021 Apr 8. ACS Med Chem Lett. 2021. PMID: 33850605 Free PMC article.
-
Identification of potential inhibitors of SARS-CoV-2 main protease and spike receptor from 10 important spices through structure-based virtual screening and molecular dynamic study.J Biomol Struct Dyn. 2022 Feb;40(2):941-962. doi: 10.1080/07391102.2020.1819883. Epub 2020 Sep 18. J Biomol Struct Dyn. 2022. PMID: 32948116 Free PMC article.
-
Innate Immune Evasion by Human Respiratory RNA Viruses.J Innate Immun. 2020;12(1):4-20. doi: 10.1159/000503030. Epub 2019 Oct 14. J Innate Immun. 2020. PMID: 31610541 Free PMC article. Review.
-
Binding Adaptation of GS-441524 Diversifies Macro Domains and Downregulates SARS-CoV-2 de-MARylation Capacity.J Mol Biol. 2022 Aug 30;434(16):167720. doi: 10.1016/j.jmb.2022.167720. Epub 2022 Jul 15. J Mol Biol. 2022. PMID: 35839840 Free PMC article.
-
Conformational plasticity of the VEEV macro domain is important for binding of ADP-ribose.J Struct Biol. 2019 Apr 1;206(1):119-127. doi: 10.1016/j.jsb.2019.02.008. Epub 2019 Feb 27. J Struct Biol. 2019. PMID: 30825649 Free PMC article.
References
-
- Chambon P. Nicotinamide mononucleotide activation of new DNA-dependent polyadenylic acid synthesizing nuclear enzyme. Biochem. Biophys. Res. Commun. 1963;11:39–43. - PubMed
-
- Holbourn K.P. A family of killer toxins. Exploring the mechanism of ADP-ribosylating toxins. FEBS J. 2006;273:4579–4593. - PubMed
-
- Hottiger M.O. Toward a unified nomenclature for mammalian ADP-ribosyltransferases. Trends Biochem. Sci. 2010;35:208–219. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources